Nantcell, Inc.
16 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Immunitybio, Inc. (to 2021)
0
Ending by 2030
Jun 2037
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 30, 2026The maintenance fee for Object Storage And Access Management Systems And Methods (US 11,662,938) comes due Nov 30, 2026. Unpaid by Jun 1, 2027, it lapses early.
- 1 fee due Dec 27, 2026The maintenance fee for Replication-Defective Adenoviruses Comprising Nucleic Acids Encoding SARS-COV-2 S Glycoprotein and Modified N Protein Comprising an Endosomal Targeting Sequence (US 11,684,668) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
- 1 fee due Jan 18, 2027The maintenance fee for Treatment of Immunosuppressed Subjects (US 11,701,408) comes due Jan 18, 2027. Unpaid by Jul 19, 2027, it lapses early.
- 2 fees due Apr 10 to 17, 2027 · next Apr 10
- 1 fee due Jul 2, 2027The maintenance fee for Bacillus Calmette-Guerin (BCG) and Antigen Presenting Cells for Treatment of Bladder Cancer (US 11,857,612) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 1 fee due Aug 6, 2027The maintenance fee for Production And Delivery Tracking And Sample Verification Of Patient-Specific Therapeutics (US 11,894,109) comes due Aug 6, 2027. Unpaid by Feb 7, 2028, it lapses early.
- 1 fee due Sep 26, 2027The maintenance fee for Systems And Methods For Performing Segmentation Based On Tensor Inputs (US 11,941,813) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.
- 1 fee due Oct 2, 2027The maintenance fee for Deep Learning Models for Region-of-Interest Determination (US 11,948,687) comes due Oct 2, 2027. Unpaid by Apr 3, 2028, it lapses early.
Recent changes
- 5 of the patents on this record were granted since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,510,982 | haNK CETUXIMAB COMBINATIONS AND METHODS In force · Medium confidence | In force | Medium confidence | |
| US 12,527,865 | haNK Cetuximab Combinations And Methods In force · High confidence | In force | High confidence | |
| US 10,973,852 | NK Cells with Altered CXCL12/CXCR4 Signaling In force · High confidence | In force | High confidence | |
| US 11,564,980 | Tumor Treatment Method with an Individualized Peptide Vaccine In force · High confidence | In force | High confidence | |
| US 11,590,217 | Neoepitope vaccine and minnune stimulant combinations and methods In force · High confidence | In force | High confidence | |
| US 12,491,201 | Maximizing T-Cell Memory and Compositions and Methods Therefor In force · High confidence | In force | High confidence | |
| US 11,779,637 | Targeted Neoepitope Vectors and Methods Therefor In force · High confidence | In force | High confidence | |
| US 12,311,018 | Targeted Neoepitope Vectors And Methods Therefor In force · High confidence | In force | High confidence | |
| US 11,311,603 | HIV Treatment Compositions and Methods In force · High confidence | In force | High confidence | |
| US 12,303,477 | HIV Treatment Compositions And Methods In force · High confidence | In force | High confidence |
Also on record, not counted in the 45: 16 patents in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
10 pending · 20 abandoned · 10 no status recorded